ROTHBLATT MARTINE A bought UTHR
June 22, 2026 · Form 4 insider transaction
ROTHBLATT MARTINE A bought 6,590 shares of United Therapeutics Corporation at $135.42 per share, a transaction worth $892.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,590
Price
$135.42
Total value
$892.4K
InsiderROTHBLATT MARTINE A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 22, 2026
Filing dateJune 24, 2026
Shares owned after47,103
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.